May 16, 2012

ASCO Abstracts Highlight Late-stage Sanofi Oncology Pipeline

- Progress on Jevtana®, Zaltrap™ and JAK2 inhibitor featured -

 

ASCO Abstracts Highlight Late-stage Sanofi Oncology Pipeline
- Progress on Jevtana®, Zaltrap™ and JAK2 inhibitor featured -

Paris, France – May 16, 2012 – Sanofi (EURONEXT: SAN and NYSE: SNY) announced today abstracts spanning the company’s innovative marketed and late-stage development compounds will be featured at the 2012 American Society of Clinical Oncology Annual Meeting in Chicago, Ill., June 1-5. Sanofi products are noted in more than 170 abstracts to be presented at the meeting.